Literature DB >> 8635422

Complex febrile seizures.

A T Berg1, S Shinnar.   

Abstract

In the context of a prospective cohort study, we examined the associations between individual complex features of both first (n = 428) and recurrent (n = 240) febrile seizures and factors shown to predict outcome in children with febrile seizures. Thirty-five percent of first and 33% of recurrent febrile seizures had one or more complex features (focal onset, duration > or = 10 min, or multiple seizures during the illness episode). There were strong correlations between focality and prolonged duration for both first and recurrent febrile seizures. A low fever at the time of the seizure was marginally associated with prolonged duration. Most factors associated with either recurrent febrile seizures or subsequent unprovoked seizures were not associated with either the initial seizure being complex or the likelihood that a recurrence would be complex. However, the children with recurrent febrile seizures, complex features tended to repeat. This factor was statistically significant and particularly striking for prolonged duration. Genetic or other constitutional factors may explain why the prolonged feature recurs. Eleven (2.5%) children had three or four risk factors for recurrent febrile seizure that was prolonged. This very small group of children may be candidates for abortive therapy to be administered at the onset of a recurrent seizure.

Entities:  

Mesh:

Year:  1996        PMID: 8635422     DOI: 10.1111/j.1528-1157.1996.tb00003.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  57 in total

Review 1.  Do febrile seizures improve memory?

Authors:  T Z Baram; S Shinnar
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

2.  Febrile Seizures and Mesial Temporal Sclerosis.

Authors:  Shlomo Shinnar
Journal:  Epilepsy Curr       Date:  2003-07       Impact factor: 7.500

Review 3.  Febrile seizures.

Authors:  Lynette G Sadleir; Ingrid E Scheffer
Journal:  BMJ       Date:  2007-02-10

4.  Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis.

Authors:  Sebastian Schuchmann; Dietmar Schmitz; Claudio Rivera; Sampsa Vanhatalo; Benedikt Salmen; Ken Mackie; Sampsa T Sipilä; Juha Voipio; Kai Kaila
Journal:  Nat Med       Date:  2006-07-02       Impact factor: 53.440

Review 5.  Febrile seizures: mechanisms and relationship to epilepsy.

Authors:  Céline M Dubé; Amy L Brewster; Tallie Z Baram
Journal:  Brain Dev       Date:  2009-02-15       Impact factor: 1.961

Review 6.  Febrile seizures and mechanisms of epileptogenesis: insights from an animal model.

Authors:  Roland A Bender; Celine Dubé; Tallie Z Baram
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

7.  MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study.

Authors:  Shlomo Shinnar; Jacqueline A Bello; Stephen Chan; Dale C Hesdorffer; Darrell V Lewis; James Macfall; John M Pellock; Douglas R Nordli; L Matthew Frank; Solomon L Moshe; William Gomes; Ruth C Shinnar; Shumei Sun
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 8.  The role of interleukin-1beta in febrile seizures.

Authors:  James G Heida; Solomon L Moshé; Quentin J Pittman
Journal:  Brain Dev       Date:  2009-02-13       Impact factor: 1.961

9.  Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures.

Authors:  Roland A Bender; Celine Dubé; Rebeca Gonzalez-Vega; Erene W Mina; Tallie Z Baram
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

10.  Design and phenomenology of the FEBSTAT study.

Authors:  Dale C Hesdorffer; Shlomo Shinnar; Darrell V Lewis; Solomon L Moshé; Douglas R Nordli; John M Pellock; James MacFall; Ruth C Shinnar; David Masur; L Matthew Frank; Leon G Epstein; Claire Litherland; Syndi Seinfeld; Jacqueline A Bello; Stephen Chan; Emilia Bagiella; Shumei Sun
Journal:  Epilepsia       Date:  2012-06-28       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.